COVID drug shows promise in new McMaster study — but will patients ever get access?
by Lauren Pelley from CBC | Edmonton News on (#68SRX)
A one-shot drug aimed at curbing severe COVID-19 is stirring excitement among scientists, given the limited treatments left to beat back serious infections - but some doubt it will ever reach patients. And Canadian research backing its use is just the latest chapter in a complicated, years-long saga to find effective, lasting options.